High Content Screening Market Driven by Futuristic Drug Delivery Methods

High content analysis or screening is commonly used in drug discovery and biological research. It is a process of visual screening and identification of small molecules, peptides, and other substances in the desired manner. Great rise in the adaptation of these methods in different phases of drug discovery are helping the global high content screening market. Innovative methods of drug discovery are expected to be a strong driver for the global market for high content analysis. Emerging markets will also provide significant investment opportunities.

For More Read this:  http://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html

Segments, Trends and Market Drivers

Global high content screening market is segmented on the basis of their products, applications, end user segment and geography. Applications of high content analysis range from primary screening, secondary screening, compound profiling, target identification, validation, toxicity studies, and other applications. The end-user segment for the industry is divided into academic institutes, government research institutes, biotechnological and pharmaceutical companies and contract research organizations are the basic end-users for these technologies. Based on geography, the industry is segmented into Europe, North America, Asia and rest of the world. Following are the details of the types of products available in the market:

  • Screening Instruments: Flow cytometers and cell imaging and analysis HCS systems
  • Microplates
  • Consumables: reagents and assay kits
  • Software
  • Services
  • Others

As mentioned before, high content screening market is expected to witness healthy growth during the forecasting period. Increasing activities in drug discovery methods, rising demand for determination of toxicity levels, and increasing number of drug discovery projects for future are some of the strongest drivers. Positive approach and financial backing from the governments, authoritative institutes and research organizations are also creating better opportunities for the existing as well as potential investors in this industry. Growth and increasing awareness about healthcare practices are encouraging emerging markets like Asia Pacific and Latin America. This growth is also creating strong opportunities within the market.

As a result of all these drivers, the global high content screening market is expected to maintain a healthy CAGR of over 11% during the forecasting period of over four to five years. From 2013 to 2018, the market is expected to maintain a CAGR of 11.2% to reach $615.8 million by 2018. In 2013, the market was worth more than $362.2 million. North America is currently dominating the global market, which is also estimated to dominate the rest of the geographic regions during the forecasting period. North America is followed by Europe and Asia. However, Asia Pacific region will witness strongest growth during the forecasting period in terms of demand and revenue.